ArticleBMC health services research2025
Hypertensive patient's journey in Poland.
Article in BMC health services research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPoor adherence to medical treatment is a significant public health issue, with nearly 50% of patients failing to comply with prescribed medications. In hypertension (HTN), self-reported non-adherence may also affect over half of patients, leading to severe consequences, including increased morbidity and mortality. Given the multifaceted nature of adherence barriers, a structured approach is needed. This study aims to analyse the Patient Journey in hypertension management within Poland, highlighting experiences, key challenges and faced emotions for both patients and physicians, as well as opportunities for improving adherence.
methodsA qualitative study was conducted using in-depth individual interviews with 12 hypertensive patients from various regions of Poland and 14 medical doctors (primary care physicians and cardiologists) from public and private healthcare facilities. The study examined patient experiences, physician perspectives, and systemic factors that influence adherence.
resultsThe patient journey in HTN management consists of six stages: pre-diagnosis, diagnosis, therapy implementation, first-year therapy, cardiovascular event, and long-term therapy. These stages differ in the barriers and emotions experienced by the patient and the clinician, allowing the focus to be directed on selected aspects that most effectively support the diagnostic and therapeutic process. Key identified patients’ barriers include lack of symptom awareness, insufficient informational support, emotional reactions to diagnosis, polypharmacy, financial constraints, and limited healthcare provider engagement. Physicians face challenges related to time constraints, limited systemic support, and patient reluctance to cooperate.
conclusionsUnderstanding the patient journey provides a structured approach to identifying modifiable adherence barriers. Addressing these factors through patient education, tailored support strategies, and improved physician-patient communication can enhance long-term adherence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.